NextGen Healthcare, Inc.
NXGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $176,418 | $178,207 | $178,550 | $161,877 |
| % Growth | -1% | -0.2% | 10.3% | – |
| Cost of Goods Sold | $94,797 | $98,386 | $94,030 | $85,349 |
| Gross Profit | $81,621 | $79,821 | $84,520 | $76,528 |
| % Margin | 46.3% | 44.8% | 47.3% | 47.3% |
| R&D Expenses | $18,020 | $20,925 | $20,027 | $19,621 |
| G&A Expenses | $0 | $0 | $73,057 | $0 |
| SG&A Expenses | $54,175 | $48,193 | $83,327 | $46,177 |
| Sales & Mktg Exp. | $0 | $0 | $10,270 | $0 |
| Other Operating Expenses | $430 | $1,188 | $1,336 | $919 |
| Operating Expenses | $73,384 | $70,306 | $104,690 | $66,717 |
| Operating Income | $8,056 | $12,234 | -$20,170 | $9,564 |
| % Margin | 4.6% | 6.9% | -11.3% | 5.9% |
| Other Income/Exp. Net | -$1,360 | -$520 | -$4,591 | -$730 |
| Pre-Tax Income | $6,696 | $8,546 | -$24,761 | $8,834 |
| Tax Expense | $1,641 | $2,390 | $479 | $1,019 |
| Net Income | $5,055 | $6,156 | -$25,240 | $7,815 |
| % Margin | 2.9% | 3.5% | -14.1% | 4.8% |
| EPS | 0.08 | 0.09 | -0.38 | 0.12 |
| % Growth | -11.1% | 123.7% | -416.7% | – |
| EPS Diluted | 0.07 | 0.09 | -0.38 | 0.12 |
| Weighted Avg Shares Out | 67,074 | 66,420 | 66,049 | 66,561 |
| Weighted Avg Shares Out Dil | 67,690 | 66,853 | 66,049 | 67,307 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,520 | $1,669 | $1,891 | $1,530 |
| Interest Expense | $3,310 | $3,239 | $3,404 | $2,239 |
| Depreciation & Amortization | $9,315 | $9,298 | $12,412 | $10,655 |
| EBITDA | $19,321 | $21,532 | -$7,758 | $20,219 |
| % Margin | 11% | 12.1% | -4.3% | 12.5% |